Fed. Circ. Finds Galderma Acne Gel Patents Obvious In IP Row
The Federal Circuit on Wednesday reversed a district court's decision in a patent infringement suit between Galderma Laboratories LP and Tolmar Inc., finding that the lower court erred in deciding that...To view the full article, register now.
Already a subscriber? Click here to view full article